Market Overview
The Global Hemodialysis And Peritoneal Dialysis Market in terms of revenue was estimated to be worth USD 162.10 Billion in 2023 and is poised to reach USD 373.86 Billion by 2032, growing at a CAGR of 9.7 % from 2024 to 2032.
The Hemodialysis and Peritoneal Dialysis Market is defined as that global market for medical equipment, consumables, and services used in dialysis therapies, which is another treatment option for patients suffering from kidney failure or even chronic kidney disease (CKD). These treatments remove excess fluid and waste products that are accumulated in the bloodstream because the kidneys cannot function properly.
Lack of organ donors’ rise in acute kidney injury (AKI), the risks involved in transplants, technological advancement, and the efforts of major players to introduce new high-value products and services are all the factors that increase the demand for hemodialysis and peritoneal dialysis. Any disease process that affects kidney function leads to chronic kidney disease, which may ultimately lead to end-stage renal disease (ESRD). The demand for dialysis consumables is going to increase with the rise in prevalence of CKD.
For example, according to the CDC report in 2023, approximately 35.5 million Americans have CKD in one year. For example, based on the data gathered by the National Institute of Diabetes and Digestive and Kidney Diseases, as many as 25,499 kidney transplants are performed annually in the United States.
With rates for diabetes and hypertension on the rise, the population is continuing to increase its incidence of renal disease and renal failure. Diabetic nephropathy is one of the most common results of both type 1 and type 2 diabetes, which is precipitated by damage done to the clusters of arteries in the kidney that allow for removing waste and results in renal dysfunction. For instance, for Spain, according to International Diabetes Federation's data at the 10th version issued in 2022, as at 2021, had 5,141.3 thousand cases of the disease Besides, on the American Kidney Fund, Inc., more than 562,000 patients with acute kidney failure are under dialysis treatment in the United States. More than 245,000 kidney transplants are now done in the United States. So therefore, it is probable it will hasten the rapidity at which market expansion would soon occur.
Throughout the last decades, the requirement for dialysis increased. For example, through FDA statistics, it shows that there are about 10,000 children in the US experiencing acute AKI. Children with acute AKI have a survival rate of approximately 38% to 43%. New-born babies with AKI have a mortality rate of 60%. The very sick babies and infants get fluid overflow after the heart surgeries or other types of medical treatments. These factors are likely to surge the demand for neonatal hemodialysis, thus fuelling the growth of the market.
The main cause of growth in the market is increased prevalence of diabetes due to age, obesity, and bad lifestyle. Diabetes is also becoming increasingly common worldwide. For example, according to the Endocrine Society estimation in January 2022, one out of every three people over 65 residing in the United States is suffering from diabetes. Despite this, the population suffering from diabetes is gradually increasing with time. This increase in the population suffering from diabetes in low-and-middle-income countries was the highest during the stated period, International Diabetes Federation reported.
Increased population aging is the prime driver behind the market. For example, according to projections made by the World Health Organization, it shows that by 2050, there will be near about 80% of older persons belonging to the low-to-middle economies. In addition, it is projected that by the year 2050, 426 million populations aged 80 plus years. With the growing geriatric population, there would be an increased number of short-term and long-term care needs, further fuelling the market growth in the global market.
Key Findings
- Rockwell Medical expanded its position in the hemodialysis market in July 2023 when it purchased the hemodialysis concentrates division from Evoqua Water Technologies.
- By acquiring Dialyss Pte Ltd in January 2022, Nextkidney BV improved its technological prowess in home hemodialysis.
Market Drivers
Increasing Prevalence of Kidney Diseases
The incidence of chronic kidney disease and end-stage renal disease gains importance, with the world population aging and lifestyle-related diseases such as diabetes and hypertension getting increasingly common. Old age individuals are more prone to the risk of age-related dysfunction of the kidneys they are at greater risks of chronic illnesses, and have a tendency to impair the function of the kidneys. This has been closely connected with the increased use of processed foods, sedentary lifestyles, and rising rates of obesity in the developed world and elsewhere, linked directly to global increases in diabetes and hypertension, among the major risk factors for chronic kidney disease.
These factors and other diagnostics advances have been the causes of more diagnoses of CKD; hence, more need for some form of treatment when functions of kidneys begin to decrease. In most patients who suffer from ESRD, dialysis has served as an essential process by which wastes and excess fluids have been removed; functions carried out normally by healthy kidneys. As a result of increasing cases of CKD and ESRD, a large percentage of patients worldwide are in dire need of hemodialysis or peritoneal dialysis as life-sustaining treatments.
Key Findings
- DaVita Inc. and Fresenius Medical Care AG & Co. KGaA inked a contract in March 2021 to increase the use of NxStage Home Hemodialysis Machines.
- According to the US Food and Drug Administration (FDA), Baxter Healthcare Corporation recalled over 280,000 bags of Dianeal peritoneal dialysis solution in 2023 because of sterility concerns regarding possible leaks.
Market Opportunities
Growing Interest in Artificial Organs and Regenerative Medicine
There will be a substantial prospect area in the market for artificial kidneys and regenerative treatments that may entirely change management strategies for the diseases concerning kidneys. Putting it in words, there would also come a time in future development when artificial kidney through engineered or implanted units, aimed at reducing dependency or to become complete alternatives to convention dialysis by performing renal natural actions, such as removal of unwanted fluids and electrolytes balancing activities. These devices may come with the promise of improving patient outcomes because continuous filtration is more natural and autonomous from routine dialysis procedures than intermittent filtration.
Through gene therapies, tissue engineering, or cell-based therapies, the regeneration treatment tries to restore kidney functions. This kind of treatment may even chronic kidney disease and eventually results in long-term resolution without dialysis through either kidney repair or otherwise stimulating healthy kidney cells to grow within the kidney. Regenerative therapies, with prosthetic kidneys, offer patients actual options away from chronic dependency on dialysis hence with the long-term expectations that are to improve their quality of life and also reduce the rate of health issues and medical spending. To patients suffering from this condition, such advancements offer long-term prospects in altering renal therapy and raising their options.
Market Restraining Factors
Risks and Complications Associated with Dialysis
While dialysis saves lives, health hazard is a very key issue for patient outcome and market penetration. Hemodialysis is one treatment which purifies the blood by an artificial kidney, whereas the other method known as peritoneal dialysis needs fluid to be infused in the abdominal cavity to filter off waste from the blood system. The main risk is infection; both interventions pose a risk of bloodstream infections or peritonitis, which is an infection of the lining of the abdomen, from contact with equipment and entry points like catheters. Besides posing a negative impact on the health of the patient, many infections require additional medical attention, increasing costs.
Cardiac complication is also very probable since the treatment is quite disturbing to the heart and veins. Fluid imbalance through imbalanced water and electrolyte might also cause cramps and oedema, hypertension and hypotension which become disturbing and must be managed urgently. All such apprehensions may deter many patients from beginning dialysis, which will further push down the adoption rate. The requirement of constant rehospitalisation makes the overall process of treatment more economically as well as bureaucratically exhausting for both patients and care givers.
Segmentation Analysis
The market scope is segmented because of by Treatment Type, by Product Type, by End-User.
By Treatment Type
Based on the Treatment Type of the market is segmented into Hemodialysis, Peritoneal Dialysis.
In-centre hemodialysis dominates the market as this process involves the treatment given at a dialysis clinic by professionals. The common type of hemodialysis includes in-centre hemodialysis since most patients prefer regular and structured care with well-trained health workers. For example, a patient with end-stage renal disease will go three days a week for four hours to the dialysis centre, where machine will filter waste and excess fluids from his blood. A patient feels more comfortable with its treatment in a controlled environment, especially due to this complicated health condition.
The other form of dialysis is peritoneal, which is performed the most at home and offers a greater degree of flexibility. There are two main types: CAPD and APD. CAPD does not require the use of a machine; the patient fills his abdominal cavity with dialysate fluid several times a day. APD uses a cycler machine that performs exchanges automatically, often at night while the patient sleeps. For instance, a working adult might prefer APD at night, which means that he could maintain his regular daily routine. Both of them offer the facility of home treatment, but in-centre hemodialysis is more favoured as it involves a support system.
By Product Type
Based on the Product Type of the market is segmented into Equipment, Consumables, Services.
The major segment dominating the market in hemodialysis and peritoneal dialysis is equipment. Such products are, for example, hemodialysis machines, and peritoneal dialysis machines, which form a very essential component for dialysis treatment. A hemodialysis machine is essential to filter a patient's blood through a dialyzer. A peritoneal dialysis machine includes a cycler that automates infusion and draining of the fluid, which is used for dialysate. A normal hemodialysis machine found in clinics tracks numerous parameters. Therefore, such an appliance is vital in securing a patient's safety while conducting a treatment session.
The market also includes consumables, which are essential in the dialysis process. This group includes dialyzers, bloodlines, catheters, dialysis fluids, concentrates, and filters that make the treatment possible. For example, dialyzers, also known as artificial kidneys, have a crucial role in filtering waste products from the blood in hemodialysis.
The market also offers dialysis machine maintenance and repair services as well as services provided by clinics on an outpatient basis. These services ensure that equipment is maintained in good working condition; hence, the patients undergoing dialysis are treated efficiently.
Regional Snapshots
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America region has the largest share of the market. It is due to an advanced healthcare system, high level of awareness of kidney diseases, and numerous dialysis centres. Hemodialysis and peritoneal dialysis facilities are well developed in the United States, and government programs such as Medicare provide coverage for dialysis treatment for eligible patients. Rising cases of diabetes and hypertension are among the key risk factors for CKD, which has therefore increased steady demand for dialysis. Technology advancements in dialysis machines and home care have made it easier to reach out to patients and ensure faster treatment.
Dialysis market share is also contributed to by Europe. In fact, the biggest market providers of dialysis services include Germany, France, and the UK. A robust regulatory framework and significant investments in healthcare infrastructure characterize the European market. The prevalence of CKD is increasing among the aging population, further leading to a growing demand for dialysis treatment. The home dialysis option is increasingly gaining prominence as patients seek flexible modalities of treatment. Although dialysis services are readily available in the Western European countries, it varies among West European countries and even between West and East European countries; further, in some regions which suffer from health care funding and availability problems.
The growth in the Asia-Pacific region is quite steep, attributed to awareness regarding CKD, enhanced health infrastructure, and an increased disposable income base. This disease is growing fast in places like China and India with the transitions of lifestyle, urbanization, and changes in diets. This would, therefore, create investment opportunities for facilities and technology in dialysis, making more facilities available to the patients. Besides, increased home dialysis in Japan reflects the quick turnaround in the treatment pattern going on in this region.
Latin America and the Middle East are emerging regions for dialysis services; however, these regions hold unique challenges. In the Latin American region, the disparities with regard to access to healthcare along with the socioeconomic factors affect dialysis service availability. There is, however, a boom in dialysis centres throughout Brazil and Mexico, in addition to the increased involvement of governments in improving their healthcare standards. The demand for dialysis in the region is rising primarily within the Middle East because of the higher incidence rate of diabetes and kidney failure, especially amongst the members of the Gulf Cooperation Council. Government initiatives to boost the infrastructure of healthcare will enhance access to available treatment by people who require it into the future of the GCC market.
Regional diversity for the hemodialysis and peritoneal dialysis market is quite high, with respect to demand as well as healthcare development in the region, where North America and Europe are leading, but a significant growth opportunity is in the Asia-Pacific and emerging markets.
List of Companies Profiled
- Baxter
- Braun SE
- Fresenius Medical Care AG
- Medtronic
- Asahi Kasei Medical Co., Ltd.
- Nipro Corp.
- DaVita
- BD
- Nikkiso Co., Ltd.
- Cantel Medical
Key Industry Developments
- Due to the possibility of exposure to harmful substances like non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) leaking from certain peroxide-cured silicone tubing used as part of the machine's hydraulics and dialysate lines, Fresenius Medical Care recalled a number of hemodialysis machines in 2023.
Report Coverage
The report will cover the qualitative and quantitative data on the Global Hemodialysis and Peritoneal Dialysis Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Report Scope and Segmentations
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 9.7 % from 2024 to 2032 |
Segmentation | By Treatment Type, By Product Type, By End-User, By Region |
Unit | USD Billion |
By Treatment Type | - Hemodialysis
- Peritoneal Dialysis
|
By Product Type | - Equipment
- Consumables
- Services
|
By End-User | - In-Centre Dialysis Facilities
- Home Dialysis
|
By Region | - North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- MEA (Saudi Arabia, South Africa, UAE, Rest Of MEA)
|
Regional Analysis
North America accounted for the highest xx% market share in terms of revenue in the The Hemodialysis And Peritoneal Dialysis market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of The Hemodialysis And Peritoneal Dialysis. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key The Hemodialysis And Peritoneal Dialysis companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global The Hemodialysis And Peritoneal Dialysis Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
The Hemodialysis And Peritoneal Dialysis Market Report is also available for below Regions and Country Please Ask for that
North America
Europe
- Switzerland
- Belgium
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherland
- Turkey
- Rest of Europe
Asia-Pacific
- India
- Australia
- Philippines
- Singapore
- South Korea
- Japan
- China
- Malaysia
- Thailand
- Indonesia
- Rest Of APAC
Latin America
- Mexico
- Argentina
- Peru
- Colombia
- Brazil
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest Of MEA
Points Covered in the Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.
- The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
- To gain insightful analyses of the The Hemodialysis And Peritoneal Dialysis market and have comprehensive understanding of the global market and its commercial landscape.
- Assess the production processes, major issues, and solutions to mitigate the development risk.
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
- Learn about the The Hemodialysis And Peritoneal Dialysis market strategies that are being adopted by leading respective organizations.
- To understand the future outlook and prospects for the The Hemodialysis And Peritoneal Dialysis market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Research Scope of the Market
- Historic year: 2019-2022
- Base year: 2023
- Forecast: 2024 to 2032
- Representation of Market revenue in USD Million
The Hemodialysis And Peritoneal Dialysis Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: